Abide Therapeutics
Pharmaceutical company developing serine hydrolase inhibitors.
Launch date
Market cap
-
Enterprise valuation
$250m (Public information from May 2019)
Company register number 56759913
Copenhagen Capital Region of Denmark (HQ)
Financials
Estimates*
| DKK | 2020 | 2021 | 2022 |
|---|---|---|---|
| Revenues | 17.7b | 16.3b | 18.2b |
| % growth | - | (8 %) | 12 % |
| Profit | 1.6b | 1.3b | 1.9b |
| % profit margin | 9 % | 8 % | 11 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $2.3m | Seed | |
$250m Valuation: $250m | Acquisition | ||
| Total Funding | $2.3m | ||
Related Content
Recent News about Abide Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.